Vivani Medical, Inc.
VANI
$1.33
-$0.03-1.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -0.81% | 8.49% | 5.56% | 13.54% | 4.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.64% | 11.22% | 11.66% | 11.34% | 6.01% |
| Operating Income | -1.64% | -11.22% | -11.66% | -11.34% | -6.01% |
| Income Before Tax | -3.04% | -14.06% | -13.30% | -10.93% | -5.51% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.04% | -14.06% | -13.30% | -10.93% | -5.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.04% | -14.06% | -13.30% | -10.93% | -5.51% |
| EBIT | -1.64% | -11.22% | -11.66% | -11.34% | -6.01% |
| EBITDA | -1.38% | -11.21% | -11.75% | -11.58% | -5.95% |
| EPS Basic | 18.75% | 2.87% | -0.40% | -0.32% | 4.91% |
| Normalized Basic EPS | 18.73% | 2.83% | -0.45% | -0.33% | 4.93% |
| EPS Diluted | -2.99% | -20.08% | -22.84% | -0.32% | 4.91% |
| Normalized Diluted EPS | 18.73% | 2.83% | -0.45% | -0.33% | 4.93% |
| Average Basic Shares Outstanding | 29.54% | 19.68% | 13.49% | 10.36% | 10.55% |
| Average Diluted Shares Outstanding | 29.54% | 19.68% | 13.49% | 10.36% | 10.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |